Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: Updated Results from a Single Center Experience

Amer Assal, MD, Diane George, MD, Monica Bhatia, MD, Divaya Bhutani, MD, Christian Gordillo, BS, Suzanne Lentzsch, MD PhD, Ran Reshef, MDMSc, Markus Y Mapara, MD PhD

Blood (2019) 134 (Supplement_1): 2043.

https://doi.org/10.1182/blood-2019-132113

Published: 2019

Journal Articles

Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)

Alexander I. Ngwube, MD, Niketa C. Shah, MD, David Jacobsohn, MD, Edward Dela Ziga, MD, Shalini Shenoy, MD

Blood (2019) 134 (Supplement_1): 370.

https://doi.org/10.1182/blood-2019-126405

Published: 2019

Journal Articles

Tumor ADAM10/ADAM17-Mediated PD-L1 Loss May Predict Poor Outcomes in Diffuse Large B Cell Lymphoma

Jacob Orme, MD PhD, Jose Villasboas, MD, Haidong Dong, MD PhD

Blood (2019) 134 (Supplement_1): 4120.

https://doi.org/10.1182/blood-2019-124189

Published: 2019

Journal Articles

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Nao Tanizawa, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Koh Shiro, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 4492.

https://doi.org/10.1182/blood-2019-124264

Published: 2019

Journal Articles

Phase 1 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm

Colin D. Godwin, MDMPhil, Megan Othus, PhD, Mary-Elizabeth M. Percival, MD, Bart L. Scott, MD, Pamela S. Becker, MD PhD, Kelda M. Gardner, PA-C, Sioban B. Keel, MD, Tejaswini M. Dhawale, MD, Vivian G. Oehler, MD, Janis L. Abkowitz, MD, Anna B. Halpern, MD, Paul C. Hendrie, MD PhD, Kaysey F. Orlowski, Alice Woo, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS

Blood (2019) 134 (Supplement_1): 3892.

https://doi.org/10.1182/blood-2019-126009

Published: 2019

Journal Articles

Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

Michael J. Burke, MD, David S. Ziegler, MBBS, FRACP, MD, Francisco José Bautista Sirvent, MD PhD, Andishe Attarbaschi, MD, Lia Gore, MD, Franco Locatelli, MD PhD, Maureen M O'Brien, MD, Melinda Pauly, MD, Mihaela Obreja, PhD, Christopher L. Morris, PhDMD, Andre Baruchel, MD

Blood (2019) 134 (Supplement_1): 3873.

https://doi.org/10.1182/blood-2019-127350

Published: 2019

Journal Articles

Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Blood (2019) 134 (Supplement_1): 765.

https://doi.org/10.1182/blood-2019-125769

Published: 2019

Journal Articles

Acute Neurotoxicity during ALL Therapy Is Associated with Treatment Intensity, Age and Female Sex - an Analysis of SAE Reports from the UKALL 2003 Trial

Qurat-ul-Ain Wahid, Lina Hamadeh, Sheena McGowan, Rachael Hough, MD BMBS, FRCP, FRCPath, Ajay Vora, MD, Anthony V. Moorman, PhD, Christina Halsey, MD PhD

Blood (2018) 132 (Supplement 1): 1379.

https://doi.org/10.1182/blood-2018-99-113267

Published: 2018

Journal Articles

Curative Allogeneic Stem Cell Transplantation Is Safe and Feasible in Adult Patients with Sickle Cell Disease Despite Lack of Matched Sibling Donor and Presence of Sickle Cell-Related Co-Morbidities

Amer Assal, MD, Diane George, MD, Monica Bhatia, MD, Christian Gordillo, BS, Nicole Howard, BS, Ran Reshef, MD MSc, Markus Y Mapara, MD PhD

Blood (2018) 132 (Supplement 1): 5713.

https://doi.org/10.1182/blood-2018-99-116538

Published: 2018

Journal Articles

Initial Results from a Phase 1 Clinical Study of bb21217, a Next-Generation Anti Bcma CAR T Therapy

Nina Shah, MD, Melissa Alsina, MD, David S Siegel, MD PhD, Sundar Jagannath, MD, Deepu Madduri, MD, Jonathan L Kaufman, MD, Ashley Turka, Lyh Ping Lam, PharmD, RPh, Monica Massaro, MPH, Kristen Hege, MD, Fabio Petrocca, MD, Jesus G. Berdeja, MD, Noopur Raje, MD

Blood (2018) 132 (Supplement 1): 488.

https://doi.org/10.1182/blood-2018-99-116953

Published: 2018

Journal Articles

Neurological Adverse Events Determine Morbidity and Mortality Post Allogeneic Hematopoietic Cell Transplantation

Ioanna Sakellari, Eleni Gavriilaki, MD, Sotirios Papagiannopoulos, Maria Gavriilaki, MD, Ioannis Batsis, Despina Mallouri, Anna Vardi, MD PhD, Varnavas Constantinou, Michalis Iskas, Marianna Masmanidou, Evangelia Yannaki, MD, Triantafyllos Geroukis, MD, Dimitrios Kazis, Vasilis Kimiskidis, Achilles Anagnostopoulos

Blood (2018) 132 (Supplement 1): 5732.

https://doi.org/10.1182/blood-2018-99-112032

Published: 2018

Journal Articles

Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post Bone Marrow Transplant: Single Center Experience and Systematic Review

Hwazen A Shash, MD, Saad Aldaama, MD, Ghufran A Al-Hawaj, MSN, Abdullah M Alfareed, MD, Sameera A Alafghani, MD

Blood (2018) 132 (Supplement 1): 5694.

https://doi.org/10.1182/blood-2018-99-115808

Published: 2018

Journal Articles

Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophic Epidermolysis Bullosa

Christen L. Ebens, MD MPH, John A McGrath, MD FRCP, FMedSci, Katsuto Tamai, MD PhD, Hovnanian Alain, MD PhD, John E. Wagner, MD, Megan Riddle, Douglas R Keene, BS, Todd E. DeFor, MS, Rebecca Tryon, MS, Mei Chen, PhD, David T Woodley, MD, Kristin Hook, MD, Jakub L Tolar, MD PhD

Blood (2018) 132 (Supplement 1): 2165.

https://doi.org/10.1182/blood-2018-99-113035

Published: 2018

Journal Articles

Assessment of Calcineurin Inhibitor-Associated Neurotoxicity in Patients with Sickle Cell Disease Receiving a Matched Sibling Donor or T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

Katharina Kleinschmidt, MD PhD, Juergen Foell, MD, Johannes Schulte, Beatrix Pfirstinger, MD, Anja Troeger, MD, Charalampos Aslanidis, PhD, Daniel Wolff, MD, Matthias Edinger, MD PhD, Ernst Holler, MD, Wolfgang Herr, MD, Angelika Eggert, MD PhD, Selim Corbacioglu, MD

Blood (2018) 132 (Supplement 1): 2088.

https://doi.org/10.1182/blood-2018-99-115988

Published: 2018

Journal Articles

Donor-Derived Marrow Mesenchymal Stem Cells Co-Transplantation Following Haploidentical Hematopoietic Stem Cell transplantation: a Multicenter Clinical Study in 35 Severe Aplastic Anemia Children

Zhenkun Wang, PhD, Limin Li, MD, Hongjuan Yu, PhD, Fenglin Cao, MD PhD, Yang Xiao, MD, Zenghui Liu, MD, Ce Shi, MD PhD, Zhiyu Liu, MD, Weijia Feng, MD, Xiaolong Liu, Jin Zhou

Blood (2017) 130 (Supplement 1): 4482.

https://doi.org/10.1182/blood.V130.Suppl_1.4482.4482

Published: 2017

Journal Articles

Long Term Followup of Sickle Cell Disease Post Hematopoietic Stem Cell Transplant from Uganda

Musa K. Waiswa, MBChB, Gaurav Kharya, Divya Bansal, MD DM, Silky Jain, Edward Kasirye, Francis N. Ssali, MBBChir, David Ndawula, Henry Ddungu, Madeleine M Verhovsek, MD FRCPC, Deogratias Munube, MD

Blood (2017) 130 (Supplement 1): 4606.

https://doi.org/10.1182/blood.V130.Suppl_1.4606.4606

Published: 2017

Journal Articles

Atypical Hemolytic Uremic Syndrome-Clinical Presentation, Treatment, and Short Term Outcomes: The Mayo Clinic Experience

Meera Sridharan, MD, Roshini Abraham, PhD, Hatem Amer, MD, Fernando Fervenza, MD, C. Christopher Hook, MD, Nelson Leung, MD, Ariela L. Marshall, MD, David L. Murray, MDPhD, Rajiv K. Pruthi, MBBS, Sanjeev Sethi, MDPhD, Maria Alice V. Willrich, PhD, Jeffrey L. Winters, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 2317.

https://doi.org/10.1182/blood.V130.Suppl_1.2317.2317

Published: 2017

Journal Articles

Clinical Profile of Posterior Reversible Encephalopathy Syndrome(PRES)-Related Epilepsy in Patients Following Haploidentical Hematopoietic Stem Cell Transplantation:a 10-Year Study

Xin Zhao, Ying-Jun Chang, Huan Chen, Wei Han, Yao Chen, MD, Yu Wang, Yuan-Yuan Zhang, Jing-Zhi Wang, Yu-Hong Chen, Feng-Rong Wang, Hai-Xia Fu, Xiao-Dong Mo, MD, Ting-Ting Han, Fei-Fei Tang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, MD, Xiaohui Zhang, MD

Blood (2017) 130 (Supplement 1): 2006.

https://doi.org/10.1182/blood.V130.Suppl_1.2006.2006

Published: 2017

Journal Articles

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

Yao-Chung LIU, MD, Ting-An Lin, MD, Po-Shen Ko, MD, Hao-Yuan Wang, MD, Sheng-Hsuan Chien, MD, Chia-Jen Liu, MD PhD, Tzeon-Jye Chiou, MD, Liang-Tsai Hsiao, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2017) 130 (Supplement 1): 4527.

https://doi.org/10.1182/blood.V130.Suppl_1.4527.4527

Published: 2017

Journal Articles

Alemtuzumab/Low Dose TBI Conditioning Facilitates Stable Long-Term Donor Hematopoietic Cell Engraftment from Sibling Donors in Children with Sickle Cell Disease

Gregory M Guilcher, MDBSc,FRCPC, Dania Monagel, MDFRCPC,FAAP, Michael Leaker, MDFRCPC, Tony H Truong, MDFRCPC, Alberto Nettel-Aguirre, PhD PStat, Aisha Bruce, MD, Catherine Corriveau-Bourque, MD, Sunil Desai, MD, Victor A. Lewis, MD

Blood (2017) 130 (Supplement 1): 4592.

https://doi.org/10.1182/blood.V130.Suppl_1.4592.4592

Published: 2017

NARROW

Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: Updated Results from a Single Center Experience

Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)

Tumor ADAM10/ADAM17-Mediated PD-L1 Loss May Predict Poor Outcomes in Diffuse Large B Cell Lymphoma

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Phase 1 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm

Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Acute Neurotoxicity during ALL Therapy Is Associated with Treatment Intensity, Age and Female Sex - an Analysis of SAE Reports from the UKALL 2003 Trial

Curative Allogeneic Stem Cell Transplantation Is Safe and Feasible in Adult Patients with Sickle Cell Disease Despite Lack of Matched Sibling Donor and Presence of Sickle Cell-Related Co-Morbidities

Initial Results from a Phase 1 Clinical Study of bb21217, a Next-Generation Anti Bcma CAR T Therapy

Neurological Adverse Events Determine Morbidity and Mortality Post Allogeneic Hematopoietic Cell Transplantation

Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post Bone Marrow Transplant: Single Center Experience and Systematic Review

Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophic Epidermolysis Bullosa

Assessment of Calcineurin Inhibitor-Associated Neurotoxicity in Patients with Sickle Cell Disease Receiving a Matched Sibling Donor or T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

Donor-Derived Marrow Mesenchymal Stem Cells Co-Transplantation Following Haploidentical Hematopoietic Stem Cell transplantation: a Multicenter Clinical Study in 35 Severe Aplastic Anemia Children

Long Term Followup of Sickle Cell Disease Post Hematopoietic Stem Cell Transplant from Uganda

Atypical Hemolytic Uremic Syndrome-Clinical Presentation, Treatment, and Short Term Outcomes: The Mayo Clinic Experience

Clinical Profile of Posterior Reversible Encephalopathy Syndrome(PRES)-Related Epilepsy in Patients Following Haploidentical Hematopoietic Stem Cell Transplantation:a 10-Year Study

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

Alemtuzumab/Low Dose TBI Conditioning Facilitates Stable Long-Term Donor Hematopoietic Cell Engraftment from Sibling Donors in Children with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only